In 2016, Lauvergeon was put under formal investigation for her role in the UraMin acquisition,[35] over questions on whether she deliberately submitted misleading annual accounts that concealed huge writedowns on its €1.8 billion investment in UraMin.[36] Also, French judicial authorities investigated Fric for insider trading and money laundering over the UraMin purchase.[37]